Tuberculosis Vaccine Treatment Market

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
Tuberculosis Vaccine Treatment Market aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine Treatment. Tuberculosis Vaccine Treatment Market contains market size and forecasts of Tuberculosis Vaccine Treatment in global, including the following market information:
Global Tuberculosis Vaccine Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Tuberculosis Vaccine Treatment Market Sales, 2018-2023, 2024-2029, (K Dose)
Global top five Tuberculosis Vaccine Treatment companies in 2022 (%)
The global Tuberculosis Vaccine Treatment market was valued at US$ 76 million in 2022 and is projected to reach US$ 92 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
We surveyed the Tuberculosis Vaccine Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Vaccine Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Dose)
Global Tuberculosis Vaccine Treatment Market Segment Percentages, by Type, 2022 (%)
Immune Vaccine
Therapy Vaccine
Global Tuberculosis Vaccine Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Dose)
Global Tuberculosis Vaccine Treatment Market Segment Percentages, by Application, 2022 (%)
Self-Procurement
UNICEF
Other
Global Tuberculosis Vaccine Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Dose)
Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis Vaccine Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Tuberculosis Vaccine Treatment revenues share in global market, 2022 (%)
Key companies Tuberculosis Vaccine Treatment sales in global market, 2018-2023 (Estimated), (K Dose)
Key companies Tuberculosis Vaccine Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tuberculosis Vaccine Treatment, market overview.
Chapter 2: Global Tuberculosis Vaccine Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tuberculosis Vaccine Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tuberculosis Vaccine Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.